Company Search:
Advanced Search
Sponsored Links
Vaxart Inc Company Snapshot
Vaxart Inc operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Vaxart Inc with three other companies in this sector in UNITED STATES : OUTLOOK THERAPEUTICS, INC. (2019 sales of $8.15 million ), Fate Therapeutics Inc ($10.68 million of which 100% was Biopharmaceuticals), and Curis, Inc. ($10.00 million of which 100% was Research and development of innovative c).

Sales Analysis. Vaxart Inc reported sales of $9.86 million for the year ending December of 2019. This represents an increase of 137.1% versus 2018, when the company's sales were $4.16 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Vaxart Inc
  Stock Performance Chart for Vaxart Inc
  Stock Data: Recent Stock Performance:
  Current Price (1/22/2021): 7.14
(Figures in U.S. Dollars)
1 Week -0.6%   13 Weeks 5.3%  
4 Weeks 26.6%   52 Weeks 1,345.3%  
Vaxart Inc Key Data:
  Ticker: VXRT Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2019 Sales 9,862,000
(Year Ending Jan 2020).
Employees: 34
  Currency: U.S. Dollars Market Cap: 781,608,267
  Fiscal Yr Ends: December Shares Outstanding: 109,468,945
  Share Type: Common Closely Held Shares: 709,153
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.